Enrica Bianchi1, Kim Boekelheide2, Mark Sigman1, Dolores J Lamb3, Susan J Hall2, Kathleen Hwang4. 1. Department of Surgery, Division of Urology, Brown University, Providence, Rhode Island; Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island. 2. Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island. 3. Department of Urology, Baylor College of Medicine, Houston, Texas. 4. Department of Surgery, Division of Urology, Brown University, Providence, Rhode Island; Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island. Electronic address: Kathleen_Hwang@brown.edu.
Abstract
BACKGROUND: Peritoneal adhesion formation is a well-recognized consequence of abdominal and pelvic surgery, causing infertility, chronic pelvic pain, and intestinal obstruction. We hypothesized that ghrelin, a 28-amino acid peptide predominantly found in the stomach, plays an important role in preventing postoperative surgical adhesions. The purpose of this study was to develop a new surgical peritoneal adhesion model to define the role that ghrelin plays in wound healing and adhesion formation. MATERIALS AND METHODS: C57BL/6 wild-type mice (n = 40) and growth hormone secretagogue receptor-knockout (GHSR KO) mice (n = 20) underwent a midline laparotomy to establish a peritoneal adhesion model characterized by the combination of two different techniques: ischemic peritoneal buttons and cecal multiple abrasion. All mice received intraperitoneal injections with ghrelin (0.16 mg/kg) or saline twice daily for 20 d after surgery. Peritoneal ischemic buttons were harvested to determine protein expression of collagen (Masson trichrome, picrosirius red stain, and Western blot). RESULTS: The novel mouse model demonstrated consistent and easily reproducible formation of intra-abdominal adhesions. Ghrelin administration significantly reduced postoperative adhesion formation (P < 0.001) in wild-type mice. The antifibrotic effect of ghrelin in wild-type mice was confirmed by measuring collagen I protein levels via Western blot analysis. The anti-adhesion effect of ghrelin seen in wild-type mice was not detected in GHSR KO mice demonstrating that this effect is mediated by the GHSR-1a receptor. CONCLUSIONS: Ghrelin administration may improve surgical outcome by reducing peritoneal adhesion formation and fibrotic response in a mouse model.
BACKGROUND: Peritoneal adhesion formation is a well-recognized consequence of abdominal and pelvic surgery, causing infertility, chronic pelvic pain, and intestinal obstruction. We hypothesized that ghrelin, a 28-amino acid peptide predominantly found in the stomach, plays an important role in preventing postoperative surgical adhesions. The purpose of this study was to develop a new surgical peritoneal adhesion model to define the role that ghrelin plays in wound healing and adhesion formation. MATERIALS AND METHODS: C57BL/6 wild-type mice (n = 40) and growth hormone secretagogue receptor-knockout (GHSR KO) mice (n = 20) underwent a midline laparotomy to establish a peritoneal adhesion model characterized by the combination of two different techniques: ischemic peritoneal buttons and cecal multiple abrasion. All mice received intraperitoneal injections with ghrelin (0.16 mg/kg) or saline twice daily for 20 d after surgery. Peritoneal ischemic buttons were harvested to determine protein expression of collagen (Masson trichrome, picrosirius red stain, and Western blot). RESULTS: The novel mouse model demonstrated consistent and easily reproducible formation of intra-abdominal adhesions. Ghrelin administration significantly reduced postoperative adhesion formation (P < 0.001) in wild-type mice. The antifibrotic effect of ghrelin in wild-type mice was confirmed by measuring collagen I protein levels via Western blot analysis. The anti-adhesion effect of ghrelin seen in wild-type mice was not detected in GHSR KO mice demonstrating that this effect is mediated by the GHSR-1a receptor. CONCLUSIONS:Ghrelin administration may improve surgical outcome by reducing peritoneal adhesion formation and fibrotic response in a mouse model.
Authors: H Ellis; B J Moran; J N Thompson; M C Parker; M S Wilson; D Menzies; A McGuire; A M Lower; R J Hawthorn; F O'Brien; S Buchan; A M Crowe Journal: Lancet Date: 1999-05-01 Impact factor: 79.321
Authors: M Binn; C Albert; A Gougeon; H Maerki; B Coulie; M Lemoyne; R Rabasa Lhoret; C Tomasetto; P Poitras Journal: Peptides Date: 2006-01-19 Impact factor: 3.750
Authors: Hugh W Grant; Michael C Parker; Malcolm S Wilson; Donald Menzies; Graham Sunderland; Jeremy N Thompson; David N Clark; Alastair D Knight; Alison M Crowe; Harold Ellis Journal: J Pediatr Surg Date: 2006-08 Impact factor: 2.545
Authors: Montserrat Moreno; Javier F Chaves; Pau Sancho-Bru; Fernando Ramalho; Leandra N Ramalho; Maria L Mansego; Carmen Ivorra; Marlene Dominguez; Laura Conde; Cristina Millán; Montserrat Marí; Jordi Colmenero; Juan J Lozano; Pedro Jares; Josep Vidal; Xavier Forns; Vicente Arroyo; Juan Caballería; Pere Ginès; Ramón Bataller Journal: Hepatology Date: 2010-03 Impact factor: 17.425
Authors: Rudy Leon De Wilde; Hans Brölmann; Philippe Robert Koninckx; Per Lundorff; Adrian M Lower; Arnaud Wattiez; Michal Mara; Markus Wallwiener Journal: Gynecol Surg Date: 2012-08-24
Authors: Aldo Rocca; Giovanni Aprea; Giuseppe Surfaro; Maurizio Amato; Antonio Giuliani; Marianna Paccone; Andrea Salzano; Anna Russo; Domenico Tafuri; Bruno Amato Journal: Open Med (Wars) Date: 2016-06-23
Authors: Deborah Stroka; Daniel Candinas; Joel Zindel; Jonas Mittner; Julia Bayer; Simon L April-Monn; Andreas Kohler; Ysbrand Nusse; Michel Dosch; Isabel Büchi; Daniel Sanchez-Taltavull; Heather Dawson; Mercedes Gomez de Agüero; Kinji Asahina; Paul Kubes; Andrew J Macpherson Journal: Nat Commun Date: 2021-12-16 Impact factor: 14.919